First Time Loading...

Oncology Institute Inc
NASDAQ:TOI

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:TOI
Watchlist
Price: 0.684 USD -24% Market Closed
Updated: May 16, 2024
Section:
 

Wall Street
Price Targets

TOI Price Targets Summary
Oncology Institute Inc

Wall Street analysts forecast TOI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TOI is 2.55 USD with a low forecast of 2.525 USD and a high forecast of 2.625 USD.

TOI Lowest Forecast
Wall Street Target
2.525 USD
269% Upside
TOI Average Forecast
Wall Street Target
2.55 USD
273% Upside
TOI Highest Forecast
Wall Street Target
2.625 USD
284% Upside
Lowest
Price Target
2.525 USD
269% Upside
Average
Price Target
2.55 USD
273% Upside
Highest
Price Target
2.625 USD
284% Upside
Oncology Institute Inc Competitors:
Price Targets
EHC
Encompass Health Corp
12% Upside
REG
Regis Healthcare Ltd
1% Downside
B
BDMS
Bangkok Dusit Medical Services PCL
23% Upside
ACHC
Acadia Healthcare Company Inc
30% Upside
EHC
Encompass Health Corp
12% Upside
REG
Regis Healthcare Ltd
1% Downside
B
BDMS
Bangkok Dusit Medical Services PCL
23% Upside
ACHC
Acadia Healthcare Company Inc
30% Upside
G
MEDANTA
Global Health Ltd
2% Downside
540975
Aster DM Healthcare Ltd
39% Upside
722
UMP Healthcare Holdings Ltd
355% Upside
A
4007
Al Hammadi Holding Co
16% Upside

Revenue
Forecast

Revenue Estimate
Oncology Institute Inc

For the last 4 years the compound annual growth rate for Oncology Institute Inc's revenue is 20%. The projected CAGR for the next 2 years is 23%.

20%
Past Growth
23%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Oncology Institute Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Oncology Institute Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
TOI intrinsic value, competitors valuation, and company profile.
DCF Valuation
TOI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TOI stock valuation using valuation multiples.
Wall Street Estimates
TOI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TOI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TOI's stock price target?
Price Target
2.55 USD

According to Wall Street analysts, the average 1-year price target for TOI is 2.55 USD with a low forecast of 2.525 USD and a high forecast of 2.625 USD.

What is Oncology Institute Inc's Revenue forecast?
Projected CAGR
23%

For the last 4 years the compound annual growth rate for Oncology Institute Inc's revenue is 20%. The projected CAGR for the next 2 years is 23%.

ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.